These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2719893)

  • 21. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
    Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
    Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal handling of beta 2-microglobulin in patients with cystic fibrosis.
    Kearns GL; Berry PL; Bocchini JA; Hilman BC; Wilson JT
    DICP; 1989 Dec; 23(12):1013-7. PubMed ID: 2690470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal function and renotropic effects of secretin in cystic fibrosis.
    Windstetter D; Schaefer F; Schärer K; Reiter K; Eife R; Harms HK; Bertele-Harms R; Fiedler F; Tsui LC; Reitmeir P; Horster M; Hadorn HB
    Eur J Med Res; 1997 Oct; 2(10):431-6. PubMed ID: 9348270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular and tubular antinatriuretic actions of low-dose angiotensin II infusion in man.
    Eiskjaer H; Sørensen SS; Danielsen H; Pedersen EB
    J Hypertens; 1992 Sep; 10(9):1033-40. PubMed ID: 1328362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation of tubular reabsorption of phosphates in patients with chronic kidney disease].
    Horáčková M; Schück O; Sotorník I; Franková J; Štollová M; Látová I; Malinská H; Urbanová J
    Vnitr Lek; 2015 Dec; 61(12):1034-8. PubMed ID: 26806498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal function in patients with cystic fibrosis.
    Aladjem M; Lotan D; Boichis H; Orda S; Katznelson D
    Nephron; 1983; 34(2):84-6. PubMed ID: 6866178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine.
    Eiermann B; Sommer N; Winne D; Schumm F; Maier U; Breyer-Pfaff U
    Xenobiotica; 1993 Nov; 23(11):1263-75. PubMed ID: 8310710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Filterable plasma concentration, glomerular filtration, tubular balance, and renal clearance of heavy metals and organic substances in metal workers.
    Araki S; Aono H; Yokoyama K; Murata K
    Arch Environ Health; 1986; 41(4):216-21. PubMed ID: 3767431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of two regimens of intravenous amino acid infusion on renal haemodynamics, renal tubular function and sodium and water homeostatic hormones in healthy humans.
    Sørensen SS; Lauridsen IN; Thomsen K; Pedersen EB
    Nephrol Dial Transplant; 1991; 6(6):410-9. PubMed ID: 1876282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal function in cystic fibrosis with special reference to the renal sodium handling.
    Berg U; Kusoffsky E; Strandvik B
    Acta Paediatr Scand; 1982 Sep; 71(5):833-8. PubMed ID: 7180453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium excretion in cystic fibrosis.
    Gruskin AB; DiLiberti JH; Baluarte HJ
    J Pediatr; 1973 Feb; 82(2):344-5. PubMed ID: 4684382
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect on renal function of essential fatty acid supplementation in cystic fibrosis.
    Strandvik B; Berg U; Kallner A; Kusoffsky E
    J Pediatr; 1989 Aug; 115(2):242-50. PubMed ID: 2754552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
    Blonde L; Wehmann RE; Steiner AL
    J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.
    DeFronzo RA; Cooke CR; Andres R; Faloona GR; Davis PJ
    J Clin Invest; 1975 Apr; 55(4):845-55. PubMed ID: 1120786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of L-arginine infusion in normotensive subjects with and without a family history of hypertension.
    Herlitz H; Jungersten LU; Wikstrand J; Widgren BR
    Kidney Int; 1999 Nov; 56(5):1838-45. PubMed ID: 10571792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relative contributions of reabsorptive rate and redistributed nephron filtration rate to changes in proximal tubular fractional reabsorption during acute saline infusion and aortic constriction in the rat.
    Bartoli E; Earley LE
    J Clin Invest; 1971 Oct; 50(10):2191-203. PubMed ID: 5116209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tubular handling of amino acids after intravenous infusion of amino acids in healthy humans.
    Tietze IN; Sørensen SS; Eiskjaer H; Thomsen K; Pedersen EB
    Nephrol Dial Transplant; 1992; 7(6):493-500. PubMed ID: 1320228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of tubular functional capacity in humans using para-aminohippurate and famotidine.
    Dowling TC; Frye RF; Fraley DS; Matzke GR
    Kidney Int; 2001 Jan; 59(1):295-303. PubMed ID: 11135083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential acute effects of aldosterone, dexamethasone, and hyperkalemia on distal tubular potassium secretion in the rat kidney.
    Field MJ; Stanton BA; Giebisch GH
    J Clin Invest; 1984 Nov; 74(5):1792-802. PubMed ID: 6501571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.